长必安胶囊对大肠癌手术预后影响的临床研究

Clinical Study on the Effect of Changbi'an Capsules on the Postoperative Prognosis of Colorectal Carcinoma

目的 :研究长必安胶囊对大肠癌手术后辅助治疗的临床意义。方法 :大肠癌术后病人 1 0 1例 ,随机分为治疗组 (根治手术 +术后服长必安胶囊 )和对照组 (单纯手术 )两组 ,随访观察术后存活与转移死亡等术后预后情况。结果 :治疗组 Dukes C期 3年存活率 70 .83% ,对照组 41 .66% (P<0 .0 5)。治疗组 3年转移死亡率 2 9.1 6% ,对照组 66.66% (P<0 .0 1 )。结论

Objective: To study the clinical significance of Changbian capsules in treating postoperation of colorectal carcinoma. Methods:101 cases of postoperation of colorectal carcinoma were randomly divided into two groups: postoperative treatment with medicine group and simply postoperative group.And their postoperative prognosis were observed, including retaining living, transferring of cancer, and dying.Results: The retaining 3 years living rates of Dukes C in both treatment group and control group were respectively 70.83%, 41.66%( P <0.05). The 3 years transferring and dying rates in both groups were respectively 29.16% and 66.66%( P <0.01). Conclusion:Changbi'an capsules may be considered as a sort of assistant treatment medicine on postoperation of colorectal carcinoma.